(redirected from benign prostatic hyperplasia)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Category filter:
BHPBrake Horsepower
BHPBrake Horse Power (engineering)
BHPBetter Home Products (est. 1994; San Francisco, CA)
BHPBehavioral Health Partnership (various locations)
BHPBehavioral Health Program (various locations)
BHPBase Horse Power
BHPBenign Prostatic Hyperplasia
BHPBrake Horse Power
BHPBima (SIL code, Indonesia)
BHPBeverly Hills Playhouse (Beverly Hills, CA)
BHPBritish Herbal Pharmacopoeia (plant drugs handbook; UK)
BHPBoiler Horsepower
BHPBusiness Honors Program
BHPBottom Hole Pressure (oil industry)
BHPBlack Hole Productions (record label)
BHPBroken Hill Proprietary Company LTD (Australia)
BHPBritish Horsepower
BHPBrent Housing Partnership (UK)
BHPBureau for Historic Preservation
BHPBlack Hills Playhouse
BHPBasic Hydrogen Peroxide
BHPBezpieczenstwo i Higiena Pracy (Poland)
BHPBerkshire Health Partners (Wyomissing, PA)
BHPBurst Header Packet
BHPBase Horsepower
BHPBétons À Haute Performance (French: High Performance Concrete)
BHPBottom Hole Pump (oil Industry)
BHPBlackett Hart & Pratt
BHPBrowning HiPower
BHPBerkshire Health Plan
BHPBulletin d'Histoire Politique (French: Political History Bulletin; Canada; est. 1992)
BHPBlood-Horse Publications
BHPBonded Hollow Point (bullet type)
BHPBureau of Health Professionals
BHPBelow Head of Passes (nautical miles)
BHPBanque de Données Hydrobiologiques et Piscicoles (French)
BHPBinboy Home Page
BHPBenign Hypertrophy of Prostate
BHPBroken Heart Productions
BHPBig Hurt Productions
BHPBrute Horse Power (shootout)
BHPBig Hairy Palm (game)
BHPBlois Hobby Products
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Photoselective vaporization of the prostate for treating benign prostatic hyperplasia. Expert Rev Med Devices 2011;8:591-5.
Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia. Urology 2009; 74:177-83.
With alpha blockers, finasteride and nettle root against benign prostatic hyperplasia. Which patients are helped by conservative therapy?
Van Breda et al., "Early results from a united states trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia," Journal of Vascular and Interventional Radiology, vol.
In our study, 39 (23.8%) had serum PSA in the range of 4 to 10 ng/mL and 25 (15.2%) patients had serum PSA more than 10 ng/mL diagnosed as benign prostatic hyperplasia. The above findings i.e.
Benign prostatic hyperplasia results in the enlargement of the prostate and may lead to the reduced urinary flow from the urinary bladder.
Benign prostatic hyperplasia (BPH) is non-cancerous cell gro-wth of the prostate gland.
This report provides comprehensive information on the therapeutic development for Benign Prostatic Hyperplasia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
* The benign prostatic hyperplasia (BPH) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for Benign Prostatic Hyperplasia in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, Japan).
Full browser ?